RECRUITING

Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia

Conditions

Advanced Malignant Solid Neoplasm Hematopoietic and Lymphoid Cell Neoplasm

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This trial investigates the experience and satisfaction of care in patients with cancer that has spread to other places in the body (advanced) and their caregivers living in underserved areas of Kenya, Nigeria, Ghana, South Africa, India and Ethiopia as part of Project Extension for Community Healthcare Outcomes (ECHO). Project ECHO is a model of medical education and care management that empowers clinicians to provide better care to more people where they live. Understanding the experiences and satisfaction of patients and caregivers may help improve healthcare workforce capacity and increase access to specialty care for the world's rural and underserved populations.

Official Title

ECHO Telementoring to Improve Quality Palliative Care in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia

Quick Facts

Study Start:2020-08-24

Study Completion:2026-12-31

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT04984551

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:CHILD, ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* PATIENT: Scheduled to receive treatment at participating primary care practice for advanced cancer * PATIENT: 18 years or older * PATIENT: Willing to be accessible to the research team for follow-up by telephone or in person * PATIENT: Prognosis of at least 1 year as ascertained by the treating physician * PATIENT: Able to read and understand English as assessed by the treating physician * CAREGIVER: Identified or self-identified as primary caregiver of the patient * CAREGIVER: Willing to be accessible to the research team for follow-up by telephone or in person * CAREGIVER: 18 years or older * CAREGIVER: Able to read and understand English as assessed by the treating physician * ECHO PARTICIPANT: Participant must be a health care provider interested to participate in the study for 2 years and understand the protocol and provide consent * ECHO PARTICIPANT: Able to read and understand English as assessed by principal investigator (PI)	* Unable to understand and sign consent

Inclusion Criteria

Exclusion Criteria

* PATIENT: Scheduled to receive treatment at participating primary care practice for advanced cancer
* PATIENT: 18 years or older
* PATIENT: Willing to be accessible to the research team for follow-up by telephone or in person
* PATIENT: Prognosis of at least 1 year as ascertained by the treating physician
* PATIENT: Able to read and understand English as assessed by the treating physician
* CAREGIVER: Identified or self-identified as primary caregiver of the patient
* CAREGIVER: Willing to be accessible to the research team for follow-up by telephone or in person
* CAREGIVER: 18 years or older
* CAREGIVER: Able to read and understand English as assessed by the treating physician
* ECHO PARTICIPANT: Participant must be a health care provider interested to participate in the study for 2 years and understand the protocol and provide consent
* ECHO PARTICIPANT: Able to read and understand English as assessed by principal investigator (PI)

* Unable to understand and sign consent

Contacts and Locations

Study Contact

Sriram Yennu

CONTACT

713-792-6085

syennu@mdanderson.org

Principal Investigator

Sriram Yennu

PRINCIPAL_INVESTIGATOR

M.D. Anderson Cancer Center

Study Locations (Sites)

M D Anderson Cancer Center

Houston, Texas, 77030

United States

Collaborators and Investigators

Sponsor: M.D. Anderson Cancer Center

Sriram Yennu, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-08-24

Study Completion Date2026-12-31

Study Record Updates

Study Start Date2020-08-24

Study Completion Date2026-12-31

Terms related to this study

Additional Relevant MeSH Terms

Advanced Malignant Solid Neoplasm
Hematopoietic and Lymphoid Cell Neoplasm